CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C17404 | BRD-K47029744 | BRD-K47029744 | -- | -- | -- | Details |
| C17405 | BRD-K47029922 | tranylcypromine | KDM1A; MAOA; MAOB | Monoamine oxidase inhibitor | -- | Details |
| C17406 | BRD-K47030799 | BRD-K47030799 | -- | -- | -- | Details |
| C17407 | BRD-K47031124 | BRD-K47031124 | -- | -- | -- | Details |
| C17408 | BRD-K47033137 | BRD-K47033137 | -- | -- | -- | Details |
| C17409 | BRD-K47034148 | BRD-K47034148 | -- | -- | -- | Details |
| C17410 | BRD-K47036706 | fluocinonide | -- | -- | -- | Details |
| C17411 | BRD-K47036878 | BRD-K47036878 | -- | -- | -- | Details |
| C17412 | BRD-K47037681 | BRD-K47037681 | -- | -- | -- | Details |
| C17413 | BRD-K47049026 | BRD-K47049026 | -- | -- | -- | Details |
| C17414 | BRD-K47052171 | BRD-K47052171 | -- | -- | -- | Details |
| C17415 | BRD-K47062996 | BRD-K47062996 | -- | -- | -- | Details |
| C17416 | BRD-K47063692 | BRD-K47063692 | -- | -- | -- | Details |
| C17417 | BRD-K47064511 | BRD-K47064511 | -- | -- | -- | Details |
| C17418 | BRD-K47070211 | BRD-K47070211 | -- | -- | -- | Details |
| C17419 | BRD-K47071092 | BRD-K47071092 | -- | -- | -- | Details |
| C17420 | BRD-K47077178 | BRD-K47077178 | -- | -- | -- | Details |
| C17421 | BRD-K47078472 | BRD-K47078472 | -- | -- | -- | Details |
| C17422 | BRD-K47081163 | BRD-K47081163 | -- | -- | -- | Details |
| C17423 | BRD-K47083242 | BRD-K47083242 | -- | -- | -- | Details |
| C17424 | BRD-K47084999 | BRD-K47084999 | -- | -- | -- | Details |
| C17425 | BRD-K47087435 | BRD-K47087435 | -- | -- | -- | Details |
| C17426 | BRD-K47092271 | BRD-K47092271 | -- | -- | -- | Details |
| C17427 | BRD-K47094330 | BRD-K47094330 | -- | -- | -- | Details |
| C17428 | BRD-K47095176 | talnetant | TACR3 | Tachykinin antagonist | -- | Details |
| C17429 | BRD-K47098496 | BRD-K47098496 | -- | -- | -- | Details |
| C17430 | BRD-K47102646 | BRD-K47102646 | -- | -- | -- | Details |
| C17431 | BRD-K47105324 | BRD-K47105324 | -- | -- | -- | Details |
| C17432 | BRD-K47105409 | AG-490 | JAK2; JAK3 | JAK inhibitor; EGFR inhibitor; ErbB2 inhibitor | -- | Details |
| C17433 | BRD-K47105955 | BRD-K47105955 | -- | -- | -- | Details |
| C17434 | BRD-K47108422 | BRD-K47108422 | -- | -- | -- | Details |
| C17435 | BRD-K47109712 | BRD-K47109712 | -- | -- | -- | Details |
| C17436 | BRD-K47113219 | BRD-K47113219 | -- | -- | -- | Details |
| C17437 | BRD-K47114202 | chlorogenic-acid | -- | -- | -- | Details |
| C17438 | BRD-K47116958 | BRD-K47116958 | -- | -- | -- | Details |
| C17439 | BRD-K47119147 | d-mannitol | -- | -- | -- | Details |
| C17440 | BRD-K47119747 | BRD-K47119747 | -- | -- | -- | Details |
| C17441 | BRD-K47121420 | BRD-K47121420 | -- | -- | -- | Details |
| C17442 | BRD-K47123716 | BRD-K47123716 | -- | -- | -- | Details |
| C17443 | BRD-K47128441 | BRD-K47128441 | -- | -- | -- | Details |
| C17444 | BRD-K47131467 | BRD-K47131467 | -- | -- | -- | Details |
| C17445 | BRD-K47143916 | BRD-K47143916 | -- | -- | -- | Details |
| C17446 | BRD-K47147974 | BRD-K47147974 | -- | -- | -- | Details |
| C17447 | BRD-K47150025 | KI-8751 | KDR | KIT inhibitor; PDGFR inhibitor; VEGFR inhibitor | -- | Details |
| C17448 | BRD-K47156219 | BRD-K47156219 | -- | -- | -- | Details |
| C17449 | BRD-K47160864 | BRD-K47160864 | -- | -- | -- | Details |
| C17450 | BRD-K47163377 | BRD-K47163377 | -- | -- | -- | Details |
| C17451 | BRD-K47164766 | BRD-K47164766 | -- | -- | -- | Details |
| C17452 | BRD-K47165178 | BRD-K47165178 | -- | -- | -- | Details |
| C17453 | BRD-K47170156 | BRD-K47170156 | -- | -- | -- | Details |
| C17454 | BRD-K47170544 | BRD-K47170544 | -- | -- | -- | Details |
| C17455 | BRD-K47173028 | BRD-K47173028 | -- | -- | -- | Details |
| C17456 | BRD-K47175449 | BRD-K47175449 | -- | -- | -- | Details |
| C17457 | BRD-K47178855 | isosorbide | -- | -- | -- | Details |
| C17458 | BRD-K47192521 | icosapent | PTGS1; PTGS2 | Platelet aggregation inhibitor | -- | Details |
| C17459 | BRD-K47197953 | BRD-K47197953 | -- | -- | -- | Details |
| C17460 | BRD-K47200630 | BRD-K47200630 | -- | -- | -- | Details |
| C17461 | BRD-K47203692 | BRD-K47203692 | -- | -- | -- | Details |
| C17462 | BRD-K47204106 | BRD-K47204106 | -- | -- | -- | Details |
| C17463 | BRD-K47207162 | zimelidine | SLC6A4 | Serotonin reuptake inhibitor | -- | Details |
| C17464 | BRD-K47212522 | BRD-K47212522 | -- | -- | -- | Details |
| C17465 | BRD-K47214596 | BRD-K47214596 | -- | -- | -- | Details |
| C17466 | BRD-K47217000 | BRD-K47217000 | -- | -- | -- | Details |
| C17467 | BRD-K47228813 | BRD-K47228813 | -- | -- | -- | Details |
| C17468 | BRD-K47228832 | BRD-K47228832 | -- | -- | -- | Details |
| C17469 | BRD-K47234370 | BRD-K47234370 | -- | -- | -- | Details |
| C17470 | BRD-K47237224 | BRD-K47237224 | -- | -- | -- | Details |
| C17471 | BRD-K47238978 | BRD-K47238978 | -- | -- | -- | Details |
| C17472 | BRD-K47240178 | BRD-K47240178 | -- | -- | -- | Details |
| C17473 | BRD-K47244735 | progesterone | CYP17A1; NR3C2; PGR | Progesterone receptor agonist | -- | Details |
| C17474 | BRD-K47247219 | BRD-K47247219 | -- | -- | -- | Details |
| C17475 | BRD-K47254434 | BRD-K47254434 | -- | -- | -- | Details |
| C17476 | BRD-K47261271 | BRD-K47261271 | -- | -- | -- | Details |
| C17477 | BRD-K47261397 | BRD-K47261397 | -- | -- | -- | Details |
| C17478 | BRD-K47271260 | BRD-K47271260 | -- | -- | -- | Details |
| C17479 | BRD-K47272214 | BRD-K47272214 | -- | -- | -- | Details |
| C17480 | BRD-K47275094 | BRD-K47275094 | -- | -- | -- | Details |
| C17481 | BRD-K47277477 | BRD-K47277477 | -- | -- | -- | Details |
| C17482 | BRD-K47278471 | diphenhydramine | HRH1 | Histamine receptor antagonist | -- | Details |
| C17483 | BRD-K47283018 | BRD-K47283018 | -- | -- | -- | Details |
| C17484 | BRD-K47284302 | BRD-K47284302 | -- | -- | -- | Details |
| C17485 | BRD-K47285393 | BRD-K47285393 | -- | -- | -- | Details |
| C17486 | BRD-K47289124 | nemonapride | DRD2; DRD3 | Dopamine receptor antagonist | -- | Details |
| C17487 | BRD-K47292239 | BRD-K47292239 | -- | -- | -- | Details |
| C17488 | BRD-K47295867 | BRD-K47295867 | -- | -- | -- | Details |
| C17489 | BRD-K47301880 | BRD-K47301880 | -- | -- | -- | Details |
| C17490 | BRD-K47303556 | BRD-K47303556 | -- | -- | -- | Details |
| C17491 | BRD-K47304736 | BRD-K47304736 | -- | -- | -- | Details |
| C17492 | BRD-K47309161 | BRD-K47309161 | -- | -- | -- | Details |
| C17493 | BRD-K47314501 | BRD-K47314501 | -- | -- | -- | Details |
| C17494 | BRD-K47323024 | methapyrilene | HRH1 | Histamine receptor antagonist | -- | Details |
| C17495 | BRD-K47324077 | BRD-K47324077 | -- | -- | -- | Details |
| C17496 | BRD-K47326075 | BRD-K47326075 | -- | -- | -- | Details |
| C17497 | BRD-K47327334 | BRD-K47327334 | -- | -- | -- | Details |
| C17498 | BRD-K47328134 | lysylphenylalanyl-tyrosine | -- | -- | -- | Details |
| C17499 | BRD-K47335880 | GMX-1778 | NAMPT | NAMPT inhibitor | -- | Details |
| C17500 | BRD-K47337578 | BRD-K47337578 | -- | -- | 4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine | Details |
| C17501 | BRD-K47338154 | BRD-K47338154 | -- | -- | -- | Details |
| C17502 | BRD-K47342144 | BRD-K47342144 | -- | -- | -- | Details |
| C17503 | BRD-K47348275 | BRD-K47348275 | -- | -- | -- | Details |